Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study

Relationship between Hemoglobin Levels Corrected by Interdialytic Weight Gain and Mortality in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study

(2017) Tatsunori Toida et al.   PLoS One

Anemia Management in the China Dialysis Outcomes and Practice Patterns Study

(2016) Li Zuo et al.   BLOOD PURIFICATION

Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease

(2016) Jehan Bahrainwala et al.   SEMINARS IN NEPHROLOGY

KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update

(2015) John T. Daugirdas et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study

(2015) Soichiro Iimori et al.   NEPHROLOGY

Factors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover study

(2015) Iain A. Gillespie et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients

(2015) Ibrahim Yılmaz et al.   RENAL FAILURE

Association of Fluid Retention With Anemia and Clinical Outcomes Among Patients With Chronic Kidney Disease

(2015) S.-C. Hung et al.   Journal of the American Heart Association

Erythropoietin Resistance Index and the All-Cause Mortality of Chronic Hemodialysis Patients

(2014) Masayuki Okazaki et al.   BLOOD PURIFICATION

Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study

(2014) Rieko Eriguchi et al.   JOURNAL OF NEPHROLOGY

A 3-Marker Index Improves the Identification of Iron Disorders in CKD Anaemia

(2014) Lucile Mercadal et al.   PLoS One

Differentiating Factors Between Erythropoiesis-Stimulating Agents: An Update to Selection for Anaemia of Chronic Kidney Disease

(2013) Walter H. Hörl   DRUGS

Erythropoiesis-stimulating agents in chronic kidney disease: What have we learned in 25 years?

(2013) Szu-Chun Hung et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Anaemia management and mortality risk in chronic kidney disease

(2013) Walter H. Hörl   Nature Reviews Nephrology

Body mass index and resistance to recombinant human erythropoietin therapy in maintenance hemodialysis patients

(2013) Maria do Sameiro-Faria et al.   RENAL FAILURE

Factors Predicting Erythropoietin Resistance among Maintenance Hemodialysis Patients

(2012) Salman Mallick et al.   BLOOD PURIFICATION

Erythropoietic Stimulating Agents and Quality of a Patient's Life: Individualizing Anemia Treatment

(2012) A. S. Kliger et al.   Clinical Journal of the American Society of Nephrology

Anemia Management and Mortality Risk in Incident Hemodialysis Patients

(2010) Michael Auerbach   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

International trends in erythropoietin use and hemoglobin levels in hemodialysis patients

(2010) Philip A. McFarlane et al.   KIDNEY INTERNATIONAL

2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

(2010) Yoshiharu Tsubakihara et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Erythropoiesis Stimulatory Agent- Resistant Anemia in Dialysis Patients: Review of Causes and Management

(2009) Mehmet Kanbay et al.   BLOOD PURIFICATION

Association between Erythropoietin Responsiveness and Body Composition in Dialysis Patients

(2008) Peter Kotanko et al.   BLOOD PURIFICATION

Serum Albumin Is Strongly Associated with Erythropoietin Sensitivity in Hemodialysis Patients

(2007) R. Agarwal et al.   Clinical Journal of the American Society of Nephrology